Collaboration is latest initiative between the national lab and UC Davis Health System
SACRAMENTO, Calif. - Lawrence Livermore National Laboratory and the UC Davis Cancer Center have agreed to collaborate on an integrated cancer program that will bring together the advanced biomedical technologies and scientists of the national laboratory with basic science researchers and faculty oncologists from UC Davis.
"This agreement signifies an institutional commitment to bringing together researchers from two different cultures: the scientists of Lawrence Livermore with the patient-centered clinical researchers of the cancer center," said Ralph deVere White, director of the UC Davis Cancer Center. "Together we can create a multidisciplinary tour de force focused on revolutionary - as opposed to evolutionary - advances in treating cancer."
"We will be combining our basic science program with the basic science program of the UC Davis Health System to bring about better methods of prevention and treatment for cancer patients," added Jim Felton, leader of the Molecular and Structural Biology Division at Lawrence Livermore. "We are very excited about the potential of this collaboration."
Scientists from the laboratory's Biology and Biotechnology Research Program, Physics and Advanced Technologies Program, Energy and Environment Program and Medical Technology Program will collaborate with UC Davis Cancer Center researchers in cancer genetics, molecular pharmacology and new drug development in investigating new approaches to cancer.
Ongoing basic science research in toxicology, carcinogenesis mutation, animal sciences and DNA repair at UC Davis will be an integral part of this collaboration as well.
Specific projects under discussion include:
* Studies of phytochemicals that may affect the development of cancer. Using high-powered computers and imaging devices, Lawrence Livermore scientists are able to detect microscopic changes
Contact: Stephen Wampler
DOE/Lawrence Livermore National Laboratory